Alyeska Investment Group, L.P. Nevro Corp Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $2.03 Million - $3.03 Million	-25,000 Reduced 8.33%	275,000 $22.3 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $30.2 Million - $49.3 Million	296,345 Added 8107.93%	300,000 $34.9 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.08 Million - $1.48 Million	-8,100 Reduced 68.91%	3,655 $510,000
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $14.7 Million - $19.7 Million	-106,736 Reduced 90.08%	11,755 $2.03 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $13.5 Million - $19.6 Million	-151,325 Reduced 56.08%	118,491 $14.2 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $16.8 Million - $21.5 Million	232,416 Added 621.43%	269,816 $21.5 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $2.47 Million - $3.49 Million	37,400	37,400 $2.58 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.